NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Investigational Pharmacy is a clinical research site located in Lake Success, New York, United States 11042.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Investigational Pharmacy has participated in 1 clinical trials.
Therapeutic areas: Arthritis, Rheumatoid.
Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Investigational Pharmacy has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Investigational Pharmacy has 1 clinical trials on record. Their work covers Arthritis, Rheumatoid.
NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Investigational Pharmacy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.